You just read:

AbbVie's SKYRIZI™ Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Severe Plaque Psoriasis

News provided by

AbbVie Canada

Feb 06, 2020, 06:00 ET